A detailed history of Jefferies Group LLC transactions in Seagen Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 1,529 shares of SGEN stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,529
Previous 5,606 72.73%
Holding current value
$0
Previous $991,000 78.91%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Sep 21, 2023

SELL
$135.27 - $180.11 $551,495 - $734,308
-4,077 Reduced 72.73%
1,529 $209,000
Q3 2022

Nov 14, 2022

BUY
$135.27 - $180.11 $571,515 - $760,964
4,225 Added 57.37%
11,589 $167,000
Q2 2022

Sep 21, 2023

SELL
$108.81 - $179.33 $651,010 - $1.07 Million
-5,983 Reduced 51.63%
5,606 $991,000
Q2 2022

Aug 15, 2022

BUY
$108.81 - $179.33 $801,276 - $1.32 Million
7,364 New
7,364 $1 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.